Educational Intervention to Adherence of Patients Treated by Capecitabine +/- Lapatinib
NCT01847599 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 65
Last updated 2017-07-21
Summary
The purpose of this study is to evaluate the efficacy of the implementation of an educational program on adherence to capecitabine alone or in combination to lapatinib.
Conditions
Interventions
- OTHER
-
Educational Intervention to enhance the adherence of Patient treated by capecitabine +/- Lapatinib
Sponsors & Collaborators
-
Centre Jean Perrin
lead OTHER
Principal Investigators
-
Isabelle VAN PRAAGH, MD · Centre Jean Perrin
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-09-06
- Primary Completion
- 2016-10-13
- Completion
- 2017-07-02
Countries
- France
Study Locations
More Related Trials
-
Maintenance Treatment With Capecitabine Versus Observation in Breast Cancer Patients
NCT00130533 ·Status: COMPLETED ·Phase: PHASE3
-
Capecitabine vs. S-1 in Unresectable or Recurrent Breast Cancer
NCT00438100 ·Status: COMPLETED ·Phase: PHASE2
-
An Open-Label, Expanded Access Protocol of Iniparib Breast Cancer
NCT01130259 ·Status: NO_LONGER_AVAILABLE
-
Trial of Lapatinib Versus Lapatinib With Capecitabine in Her2+ Metastatic Gastro-Esophageal Cancer
NCT01145404 ·Status: TERMINATED ·Phase: PHASE2
-
A Study to Examine the Effects of Low and High-fat Meals on Orally Administered Lapatinib in Metastatic ErbB2 Positive Breast Cancer Patients
NCT00821054 ·Status: COMPLETED ·Phase: PHASE1
-
Lapatinib and Tamoxifen in Treating Patients With Advanced or Metastatic Breast Cancer
NCT00424164 ·Status: COMPLETED ·Phase: PHASE1
-
Capecitabine as NeoAdjuvant Therapy in Locally Advanced Breast Cancer
NCT00347438 ·Status: TERMINATED ·Phase: PHASE2
-
Letrozole Plus Metronomic Capecitabine as First-line Treatment for Patients With Recurrent or Metastatic Breast Cancer
NCT04942899 ·Status: UNKNOWN ·Phase: PHASE2
-
Pharmaceutical Care for Patients Using Capecitabine
NCT07063706 ·Status: COMPLETED ·Phase: NA
-
Study of Prophylactic Octreotide to Prevent or Reduce the Frequency and Severity of Diarrhoea in Subjects Receiving Lapatinib With Capecitabine for the Treatment of Metastatic Breast Cancer
NCT02294786 ·Status: TERMINATED ·Phase: PHASE2
-
Phase I Study of Ixabepilone Plus Lapatinib With or Without Capecitabine in the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer
NCT00634088 ·Status: TERMINATED ·Phase: PHASE1
-
Intermittent High-Dose Lapatinib in Tandem With Capecitabine for HER2 Overexpressed/Amplified Metastatic Breast Cancer With Central Nervous System (CNS) Metastases
NCT02650752 ·Status: COMPLETED ·Phase: PHASE1
-
Capecitabine Associated With Weekly Paclitaxel in Metastatic Breast Cancer.
NCT00270491 ·Status: COMPLETED ·Phase: PHASE2
-
Predicting Response to Capecitabine in Women With Metastatic Breast Cancer
NCT00953537 ·Status: COMPLETED ·Phase: NA
-
EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
NCT00338247 ·Status: APPROVED_FOR_MARKETING
-
Dose Finding Study for Combination of Capecitabine, Lapatinib and Vinorelbine in Metastatic Breast Cancer
NCT01238029 ·Status: TERMINATED ·Phase: PHASE1
-
Capecitabine In Combination With Cemiplimab In Patient With Metastatic Breast Cancer
NCT05064085 ·Status: COMPLETED ·Phase: PHASE1
-
Lapatinib in Combination With Docetaxel in Patients With HER-2 Positive Advanced or Metastatic Breast Cancer
NCT01044485 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of Pyrotinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+Metastatic Breast Cancer Who Have Prior Received Anthracyclin, Taxane or Trastuzumab
NCT02422199 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Study of the Impact of DPD Activity on the Efficacy of Capecitabine
NCT04198727 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Capecitabine Plus Radiotherapy for Local Relapse Breast Cancer With Negative Her2 Tumours
NCT00434941 ·Status: TERMINATED ·Phase: PHASE2
-
Combination Study of a New Taxane and Capecitabine in Patients With Metastatic Breast Cancer
NCT00327743 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Breast Cancer Trial of RPR109881 Versus Capecitabine in Male or Female Patients With Advanced Breast Cancer
NCT00081796 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
NCT00087620 ·Status: TERMINATED ·Phase: PHASE4
-
Capecitabine in Women With Operable Breast Cancer
NCT00148720 ·Status: TERMINATED ·Phase: PHASE2